Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.23 USD | +7.58% | +1.21% | -6.69% |
Jun. 07 | Recursion Pharmaceuticals Insider Sold Shares Worth $871,000, According to a Recent SEC Filing | MT |
May. 24 | Recursion Names HilleVax CEO Robert Hershberg as New Board Chair | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.49% | 2.04B | |
+16.78% | 124B | |
+16.67% | 109B | |
-7.27% | 23.84B | |
+1.98% | 22.42B | |
-14.29% | 17.5B | |
-7.32% | 16.61B | |
-37.63% | 16.43B | |
+2.12% | 13.4B | |
+23.80% | 11.47B |
- Stock Market
- Equities
- RXRX Stock
- News Recursion Pharmaceuticals, Inc.
- Goldman Sachs Adjusts Recursion Pharmaceuticals' Price Target to $8 From $7, Keeps Neutral Rating